New treatment options expand management of relapsed or refractory disease.
Kami Maddocks, MD
Advertisement
Articles by Kami Maddocks, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
CGTLive®’s Weekly Rewind – December 12, 2025
2
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
3
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
4
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
5
